vs
Side-by-side financial comparison of CHAMPIONS ONCOLOGY, INC. (CSBR) and Soluna Holdings, Inc (SLNH). Click either name above to swap in a different company.
CHAMPIONS ONCOLOGY, INC. is the larger business by last-quarter revenue ($15.0M vs $8.4M, roughly 1.8× Soluna Holdings, Inc). CHAMPIONS ONCOLOGY, INC. runs the higher net margin — 1.8% vs -284.7%, a 286.5% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs 11.5%). CHAMPIONS ONCOLOGY, INC. produced more free cash flow last quarter ($-2.0M vs $-6.8M). Over the past eight quarters, CHAMPIONS ONCOLOGY, INC.'s revenue compounded faster (11.8% CAGR vs -8.8%).
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
CSBR vs SLNH — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0M | $8.4M |
| Net Profit | $268.0K | $-24.0M |
| Gross Margin | 51.7% | 9.5% |
| Operating Margin | 1.2% | -92.5% |
| Net Margin | 1.8% | -284.7% |
| Revenue YoY | 11.5% | 11.8% |
| Net Profit YoY | -63.2% | -233.2% |
| EPS (diluted) | $0.02 | $-1.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.0M | — | ||
| Q3 25 | $14.0M | $8.4M | ||
| Q2 25 | $12.4M | $6.2M | ||
| Q1 25 | $17.0M | $5.9M | ||
| Q4 24 | $13.5M | $8.3M | ||
| Q3 24 | $14.1M | $7.5M | ||
| Q2 24 | $14.0M | $9.7M | ||
| Q1 24 | $12.0M | $12.5M |
| Q4 25 | $268.0K | — | ||
| Q3 25 | $-436.0K | $-24.0M | ||
| Q2 25 | $-1.8M | $-7.4M | ||
| Q1 25 | $4.5M | $-7.6M | ||
| Q4 24 | $728.0K | $-40.0M | ||
| Q3 24 | $1.3M | $-7.2M | ||
| Q2 24 | $-109.0K | $-10.9M | ||
| Q1 24 | $-2.5M | $-5.3M |
| Q4 25 | 51.7% | — | ||
| Q3 25 | 42.9% | 9.5% | ||
| Q2 25 | 41.1% | 6.3% | ||
| Q1 25 | 61.2% | 5.7% | ||
| Q4 24 | 44.9% | -360.8% | ||
| Q3 24 | 49.7% | -39.1% | ||
| Q2 24 | 48.2% | 34.6% | ||
| Q1 24 | 34.7% | 45.4% |
| Q4 25 | 1.2% | — | ||
| Q3 25 | -3.8% | -92.5% | ||
| Q2 25 | -16.2% | -107.6% | ||
| Q1 25 | 26.4% | -120.9% | ||
| Q4 24 | 5.4% | -426.0% | ||
| Q3 24 | 9.5% | -119.8% | ||
| Q2 24 | -1.9% | -38.0% | ||
| Q1 24 | -21.4% | 3.2% |
| Q4 25 | 1.8% | — | ||
| Q3 25 | -3.1% | -284.7% | ||
| Q2 25 | -14.9% | -119.9% | ||
| Q1 25 | 26.4% | -127.3% | ||
| Q4 24 | 5.4% | -483.8% | ||
| Q3 24 | 9.3% | -95.5% | ||
| Q2 24 | -0.8% | -112.4% | ||
| Q1 24 | -21.1% | -41.9% |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $-0.03 | $-1.14 | ||
| Q2 25 | $-0.12 | $-0.93 | ||
| Q1 25 | $0.31 | $-1.21 | ||
| Q4 24 | $0.05 | $-7.14 | ||
| Q3 24 | $0.09 | $-1.56 | ||
| Q2 24 | $-0.01 | $-3.62 | ||
| Q1 24 | $-0.19 | $-2.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.5M | — |
| Total DebtLower is stronger | — | $13.3M |
| Stockholders' EquityBook value | $4.2M | $14.5M |
| Total Assets | $30.2M | $152.0M |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.5M | — | ||
| Q3 25 | $10.3M | — | ||
| Q2 25 | $9.8M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $4.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $13.3M | ||
| Q2 25 | — | $10.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $8.1M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | — |
| Q4 25 | $4.2M | — | ||
| Q3 25 | $3.5M | $14.5M | ||
| Q2 25 | $3.8M | $-19.5M | ||
| Q1 25 | $5.5M | $-16.1M | ||
| Q4 24 | $681.0K | $-12.5M | ||
| Q3 24 | $-332.0K | $20.9M | ||
| Q2 24 | $-1.9M | $24.4M | ||
| Q1 24 | $-2.1M | $21.5M |
| Q4 25 | $30.2M | — | ||
| Q3 25 | $30.5M | $152.0M | ||
| Q2 25 | $32.3M | $92.0M | ||
| Q1 25 | $30.6M | $90.0M | ||
| Q4 24 | $25.2M | $88.0M | ||
| Q3 24 | $24.9M | $97.3M | ||
| Q2 24 | $26.1M | $98.7M | ||
| Q1 24 | $26.8M | $90.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-2.2M |
| Free Cash FlowOCF − Capex | $-2.0M | $-6.8M |
| FCF MarginFCF / Revenue | -13.1% | -81.4% |
| Capex IntensityCapex / Revenue | 1.6% | 55.2% |
| Cash ConversionOCF / Net Profit | -6.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.6M | $-34.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $600.0K | $-2.2M | ||
| Q2 25 | $6.9M | $-1.1M | ||
| Q1 25 | $490.0K | $-177.0K | ||
| Q4 24 | $-283.0K | $-5.1M | ||
| Q3 24 | $311.0K | $61.0K | ||
| Q2 24 | $-1.8M | $-7.3M | ||
| Q1 24 | $-919.0K | $3.9M |
| Q4 25 | $-2.0M | — | ||
| Q3 25 | $554.0K | $-6.8M | ||
| Q2 25 | $6.6M | $-9.7M | ||
| Q1 25 | $448.0K | $-4.0M | ||
| Q4 24 | $-377.0K | $-13.9M | ||
| Q3 24 | — | $-3.4M | ||
| Q2 24 | $-1.8M | $-7.6M | ||
| Q1 24 | $-1.0M | $3.3M |
| Q4 25 | -13.1% | — | ||
| Q3 25 | 4.0% | -81.4% | ||
| Q2 25 | 53.5% | -156.8% | ||
| Q1 25 | 2.6% | -67.1% | ||
| Q4 24 | -2.8% | -168.3% | ||
| Q3 24 | — | -44.8% | ||
| Q2 24 | -13.0% | -78.2% | ||
| Q1 24 | -8.4% | 26.5% |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 0.3% | 55.2% | ||
| Q2 25 | 2.0% | 139.0% | ||
| Q1 25 | 0.2% | 64.2% | ||
| Q4 24 | 0.7% | 107.0% | ||
| Q3 24 | 0.0% | 45.6% | ||
| Q2 24 | 0.0% | 2.5% | ||
| Q1 24 | 0.8% | 4.2% |
| Q4 25 | -6.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | -0.39× | — | ||
| Q3 24 | 0.24× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSBR
| Pharmacology Services | $14.5M | 97% |
| Other | $520.0K | 3% |
SLNH
| Data Hosting Revenue | $5.3M | 62% |
| Cryptocurrency Mining Revenue | $2.8M | 33% |
| Other | $389.0K | 5% |
